Comparing the Benefit of Novel Therapies Across Clinical Trials: Insights From the VICTORIA Trial

Circulation. 2020 Aug 25;142(8):717-719. doi: 10.1161/CIRCULATIONAHA.120.047086. Epub 2020 Mar 28.

Authors

Javed Butler¹, Kevin J Anstrom², Paul W Armstrong³

Affiliations

¹ Department of Medicine, University of Mississippi Medical Center, Jackson (J.B.).
² Duke Clinical Research Institute, Duke University, Durham, NC (K.J.A.).
³ Canadian VIGOUR Centre, University of Alberta, Edmonton, Canada (P.W.A.).

PMID: 32223438
DOI: 10.1161/CIRCULATIONAHA.120.047086

No abstract available

Keywords: clinical trial; heart failure; prognosis.

Publication types

Comparative Study
Research Support, N.I.H., Extramural
Review

MeSH terms

Clinical Trials as Topic
Heart Failure / drug therapy*
Heart Failure / mortality
Heart Failure / physiopathology
Heterocyclic Compounds, 2-Ring / therapeutic use*
Humans
Multicenter Studies as Topic
Pyrimidines / therapeutic use*

Substances

Heterocyclic Compounds, 2-Ring
Pyrimidines
vericiguat

Grants and funding

U54 GM115428/GM/NIGMS NIH HHS/United States